Photo by Dwxn via Wikimedia Commons New research reveals that patients with moderate-to-severe atopic dermatitis (AD) who did not...

Patients with moderate to severe hidradenitis suppurativa (HS) treated with secukinumab demonstrate sustained efficacy and symptom...

Children with eczema between the ages of six months and six years benefit from treatment with dupilumab, according to the results of a...

An early study of litifilimab, a humanized monoclonal antibody, has indicated it may be effective in the treatment of cutaneous lupus...

A study in the British Journal of Dermatology appears to show that alcohol misuse can be associated with poor response to systemic...

Study results indicate that maintenance doses of bimekizumab (320 mg) every four or eight weeks can maintain high levels of skin...

A retrospective study from the Taiwan National Health Insurance Research Database of 92,374 patients with psoriasis indicates that those...

New research from Italy indicates that patients with psoriasis who have been treated with biologic therapies may have a lesser risk of...